A detailed history of Quest Partners LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Quest Partners LLC holds 404 shares of UTHR stock, worth $133,962. This represents 0.02% of its overall portfolio holdings.

Number of Shares
404
Previous 3,500 88.46%
Holding current value
$133,962
Previous $770 Million 87.94%
% of portfolio
0.02%
Previous 0.16%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$210.76 - $249.51 $652,512 - $772,482
-3,096 Reduced 88.46%
404 $92.8 Million
Q4 2023

Feb 09, 2024

BUY
$214.88 - $256.94 $752,080 - $899,290
3,500 New
3,500 $770 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $15.1B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.